Many biomarkers, such as amyloid precursor protein (APP), β‐site APP‐cleaving enzyme 1 (BACE1), Aβ peptide 1–42 (Aβ1‐42), and tau‐5, are associated with AD progression (Weng et al., 2020). The gene discussed is BACE1; the disease is Alzheimer disease.